AlphaRx Inc.

http://www.alpharx.com

AlphaRx is developing several drug products in the therapeutic categories of Osteoarthritis and Infectious Disease. AlphaRx intends to file IND and NDA submissions with the FDA (when necessary) and license these products to other pharmaceutical companies for worldwide commercialization. The following is a list of AlphaRx's Pharmaceutical Products in the pipeline: Name Indication Delivery Route Stage Indaflex Ô Osteoarthritis Topical Phase II Streptomycin NDS Ô Tuberculosis Oral Preclinical Zysolin Ô Infection Parenteral Preclinical

• 12/8/2013
• 13
• 0